FOLFIRINOX + NIS793 in Pancreatic Cancer

Clinical trial NCT05417386 · TERMINATED

Trial details

NCT number: NCT05417386
Sponsor: Colin D. Weekes, M.D., PhD
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreas Cancer Metastatic Pancreatic Cancer Metastatic Pancreatic Adenocarcinoma

Start date: 2022-08-09
Primary completion: 2023-07-10
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.